logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Fred Hutchinson Cancer Center


USPTO Granted Patents = 289



Trademarks = 14

Forward Citations = 2,759

Loading Chart...
Loading Chart...

400 inventors (with patents filed for the assignee):

goldMedal Stanley R Riddell (26 out of 28 patents)

silverMedal James M Olson (16 out of 17 patents)

bronzeMedal Philip D Greenberg (15 out of 20 patents)

4.  Thomas M Schmitt (13 out of 16 patents)

5.  Irwin D Bernstein (11 out of 11 patents)

6.  Harlan Saul Robins (11 out of 31 patents)

7.  James M Roberts (10 out of 39 patents)

8.  Julian Simon (9 out of 9 patents)

9.  Roland K Strong (8 out of 8 patents)

10.  Colin Correnti (8 out of 9 patents)

11.  Mandana Veiseh (8 out of 19 patents)

12.  A Dusty Miller (8 out of 9 patents)

13.  Stephen J Tapscott (7 out of 9 patents)

14.  Hans-Peter Kiem (7 out of 9 patents)

15.  Matthias Stephan (7 out of 7 patents)


Core Competencies:
Facioscapulohumeral Muscular Dystrophy
WT1 T Cell Receptors
Genomic Safe Harbors
Immune Repertoire Sequencing
Deep Mutational Scanning
Immunomodulatory Fusion Proteins
BRAF-Specific TCRs
Adoptive Cell Therapy
Bispecific Antibodies
Targeted Genetic Therapies
Cell-Based Neoantigen Vaccines
Combination Therapies

289 patents:

1. 12458668 - Methods for treating facioscapulohumeral muscular dystrophy (2025-11-04),
2. 12448430 - High avidity WT1 T cell receptors and uses thereof (2025-10-21),
3. 12442021 - Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies (2025-10-14),
4. 12428682 - Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing (2025-09-30),
5. 12421626 - Cell-stored barcoded deep mutational scanning libraries and uses of the same (2025-09-23),
6. 12398402 - Reducing CD33 expression to selectively protect therapeutic cells (2025-08-26),
7. 12398191 - BRAF-specific TCRs and uses thereof (2025-08-26),
8. 12385070 - Homology directed repair compositions for the treatment of hemoglobinopathies (2025-08-12),
9. 12365906 - Immunomodulatory fusion proteins and uses thereof (2025-07-22),
10. 12351618 - Engineered trimeric CD70 proteins and uses thereof (2025-07-08),
11. 12350312 - Methods for improving adoptive cell therapy (2025-07-08),
12. 12344653 - Antigen binding molecules for small cell lung cancer (2025-07-01),
13. 12295973 - Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells (2025-05-13),
14. 12257325 - Chelating platform for delivery of radionuclides (2025-03-25),
15. 12193994 - Combination of a cell therapy and a gamma secretase inhibitor (2025-01-14),
Fred Hutchinson Cancer Research Center is a world-renowned research institution dedicated to preventing, diagnosing, and treating cancer, HIV/AIDS, and other related diseases. With a mission to eliminate these diseases as causes of human suffering, the center conducts groundbreaking research, collaborates with other leading institutions, and provides state-of-the-art patient care.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
289 Patents

#8 in Seattle, WA

#20 in Washington

#1,454 in US

#2,986 in the World

...
Seattle, WA, United States of America

Fred Hutchinson Cancer Center

Forward Citations = 2,759

400 inventors:

goldMedal Stanley R Riddell (26 out of 28 patents)

silverMedal James M Olson (16 out of 17 patents)

bronzeMedal Philip D Greenberg (15 out of 20 patents)

4.  Thomas M Schmitt (13 out of 16 patents)

5.  Irwin D Bernstein (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…